Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 1, 2002, Pages 153-158

  Bazzoli, F ^a,c   Zagari, R M ^a   Pozzato, P ^a   Fossi, S ^a   Ricciardiello, L ^a   Nicolini, G ^a   De Luca, L ^a   Berretti, D ^a   Alampi, G ^a   Di Pietro, C ^b   Morelli, P ^b   Roda, E ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Takeda Italia Farmaceutici SpA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; UREA; UREASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GLOSSITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TASTE DISORDER; TREATMENT OUTCOME; UREA BREATH TEST; VAGINITIS;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG COSTS; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; TREATMENT OUTCOME;

EID: 0036165789     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01141.x     Document Type: Article

References (29)

1. Current European concepts in the management of Helicobacter pylori infection
2. Canadian Helicobacter pylori Consensus Conference
3. The MACH 1 study: Optimal one-week treatment for Helicobacter pylori defined?
4. Short-term low-dose triple therapy for the eradication of Helicobacter pylori
5. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori
6. One week low-dose triple therapy for the eradication of Helicobacter pylori infection
7. Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection
8. Evaluation of the short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double blind, controlled study
9. Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin
10. 13C-urea breath test for the detection of Helicobacter pylori
11. Urea breath test for the detection of Helicobacter pylori infection
12. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens
13. The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
14. On the behalf of participants of AZM-I-96-001 study. Antimicrobial resistance of Helicobacter pylori in a large population of duodenal ulcer patients in Italy
15. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: The MACH 2 study
16. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: Multicenter validation study
17. Evaluation of risk factors in the surveillance of Helicobacter pylori antimicrobial resistance partnership (SHARP) in the United States from 1993-1999
18. H. pylori antimicrobial resistance in the United States: Preliminary results of a 9-center study
19. Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: A multicentre study
20. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori
21. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase
22. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: An Asian multicentre double-blind randomized placebo controlled study
23. Triple therapy for Helicobacter pylori eradication: A comparison of pantoprazole once versus twice daily
24. Regular review: Treatment of Helicobacter pylori infection
25. Maastricht consensus report regimen for second-line treatment of H. pylori infection: How does it perform in practice?
26. Clinical practice results of quadruple treatment in Helicobacter pylori eradication failure with OCA-7
27. Quadruple therapy with omeprazole, tetracycline, metronidazole, and bismuth as a second option after failure of a first eradication therapy
28. Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: A detailed, prospective analysis of 21 consecutive cases
29. High-dose omeprazole/amoxycillin therapy versus quadruple therapy against Helicobacter pylori resistant against both metronidazole and clarithromycin. A prospective, randomized, cross-over study